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Does fibromyalgia have an effect on hearing loss in women?
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Background/aim: Fibromyalgia (FM) patients may have several neuroendocrine dysfunctions, resulting in a hypervigilant sensory
output that may be responsible for sensorineural complaints. In this study, we evaluated the audiological findings of a cohort of female
fibromyalgia patients.
Materials and methods: Between 1 September 2012 and 1 June 2013, 35 female FM patients, followed by the Department of Physical
Medicine and Rehabilitation, Faculty of Medicine, Bozok University, were recruited for the study. The patients were referred to the
Department of Otolaryngology for routine otolaryngological and audiological evaluations. Age range was between 30 and 65 years, with
a mean age of 48.10 years. The control group consisted of 25 healthy female volunteers ranging from 32 to 65 years (mean age: 45.52).
All subjects were audiologically tested, including tympanometric evaluation. Low- and high-frequency audiometry was carried out by a
single experienced investigator under standard audiometric testing conditions.
Results: At low frequencies, the mean air conduction threshold values between the two groups were not statistically significant. At high
frequencies, the mean air conduction threshold values and tympanometric values between the FM and control groups were statistically
significant (P < 0.05 for both).
Conclusion: Our results point to a pathophysiologic link between FM and the development of audiological abnormalities in these
patients.
Key words: Fibromyalgia, hearing loss, frequency

1. Introduction
Fibromyalgia (FM) is a disease of unknown etiology
characterized by systemic symptoms such as fatigue,
chronic pain, sleep dysfunction numbness, and muscle
stiffness. Diagnosis is based on complaints of extensive
pain persisting for at least 3 months and reports of pain
from 4 kgF pressure in at least 11 of 18 tender points on
the body (1). Specific diagnostic criteria for FM were first
published by Smythe and Moldofsky in 1971 and were later
revised by the American College of Rheumatology (2).
Additionally, FM patients show symptoms of poor
mental health and cold intolerance. FM may also impact
quality of life by causing functional disability (3). This
syndrome is mostly seen in females, with a female-to-male
ratio of 6–9/1 (4,5).
Recent studies have shown that several neuroendocrine
dysfunctions may accompany FM, including serotonin
deficiency, increased cerebrospinal fluid substance
P, disturbance of non-REM sleep, and involvement
of the caudate nuclei (6). It has been proposed that
* Correspondence: drzeliha19@hotmail.com

these pathologic conditions may be derived from the
dysfunction of the mechanisms responsible for their
regulation as a result of the reduction of blood supply to
the targeted areas. As reported previously, FM may distort
blood supply to the inner ear structures (7).
In this study, we aim to evaluate hearing levels in a
group of FM patients using audiometric measurements.
2. Materials and methods
The study was approved by the Local Research Ethics
Committee. All patients provided written informed
consent to participate in the study according to the
Declaration of Helsinki. This was a case-control study,
enrolling 35 patients with FM (mean age: 48.10, range:
30–65 years) and 25 healthy volunteers without chronic
disease as the control group (mean age: 45.52, range: 32–
65 years) between September 2012 and June 2013 at Bozok
University. All the study and control subjects were female,
in relative accordance with the frequency of the condition.
All patients and control subjects agreed to participate in
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the study. FM was diagnosed according to the criteria of
the American College of Rheumatology (2). These criteria
include diffuse pain and stiffness in the muscles, as well as
tendon insertions on digital palpation with an approximate
force of 4 kg (the amount of pressure required to blanch
a thumbnail), lasting for at least 3 months. To meet the
diagnostic criteria, pain must occur in 11 or more of the 18
specified tender point sites. Routine ENT examination was
performed in both groups.
Subjects were excluded if they had a history of systemic
or chronic disease, chronic use of medications, previous
history of otologic disease, family history of early onset
hearing loss, hearing loss due to other causes, or a history
of high-risk noise exposure or ototoxic drug therapy.
2.1. Audiological evaluation
Otoscopic examination revealed normal external ear canal
and tympanic membrane findings in all 60 subjects. Each
subject was tested with low- (250–2000 Hz) and highfrequency (4000–8000 Hz) audiometry, performed by a
single experienced investigator in a sound-treated room.
The standard battery of hearing tests consisted of pure tone,
speech, and impedance audiometry and was performed in
the same audiology laboratory. For each set of tests, the
mean values of air and bone conduction at each frequency
value were calculated for both groups.
Tympanometric results were classified as type A, B, or
C tympanograms. Acoustic reflexes were simultaneously
recorded and evaluated.

2.2. Statistical analysis
Analysis of variance was used to analyze differences in
baseline data between the two groups. Student’s t-test and
the chi-square test were used to compare air conduction,
bone conduction, and tympanogram results in the three
groups. P ˂ 0.05 was considered to indicate statistical
significance. Data were analyzed with SPSS 15.0 (SPSS
Inc., Chicago, IL, USA). Results are expressed as mean ±
SD.
3. Results
The mean age of patients with FM was 48.10 ± 9.4 years
(30–65 years) and mean age was 45.52 ± 10.8 years (32–
65 years) for the control group. There was no statistically
significant difference between the groups with regard to
mean age (P ˃ 0.05). The hearing levels at low and high
frequencies are shown in Table 1. At low (250–2000 Hz)
frequencies, the mean air and bone conduction threshold
values between the two groups were not statistically
significant (P ˃ 0.05). In contrast, at high frequencies
(4000–8000 Hz), air-bone conduction threshold values in
the FM group were lower than in the control group, which
proved to be statistically significant (P < 0.05). The speech
discrimination score (SDS) of these patients was also
diminished; however, these values did not reach statistical
significance compared to control group’s values (P ˃ 0.05)
(Table 1).

Table 1. Comparison of the mean air conduction thresholds for the two groups at different frequencies.
Frequencies
250 Hz
500 Hz
1000 Hz
2000 Hz
4000 Hz
6000 Hz
8000 Hz
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Fibromyalgia (n = 35)

Control (n = 25)

P

Right

10.35 ± 5.31

10.02 ± 5.2

>0.05

Left

10.25 ± 5.35

10.10 ± 5.61

>0.05

Right

11.35 ± 5.11

10.90 ± 5.2

>0.05

Left

11.39 ± 6.22

11.01 ± 5.55

>0.05

Right

13.34 ± 6.12

13.15 ± 7.1

>0.05

Left

13.37 ± 6.99

13.32 ± 7.04

>0.05

Right

15.01 ± 6.45

15.01 ± 6.98

>0.05

Left

15.60 ± 7.50

15.36 ± 7.19

>0.05

Right

19.80 ± 7.70

15.13 ± 7.20

<0.05

Left

21.42 ± 7.72

15.06 ± 7.31

<0.05

Right

25.76 ± 8.33

15.11 ± 7.22

<0.05

Left

25.83 ± 8.67

15.62 ± 7.21

<0.05

Right

30.22 ± 8.60

17.17 ± 8.41

<0.05

Left

31.14 ± 9.15

17.12 ± 8.81

<0.05
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Table 2. Tympanometric values of the two groups.
Tympanometric values
Pressure
Compliance

Fibromyalgia (n = 35)

Control (n = 25)

Right

29.2 ± 11.1

22.3 ± 13.4

Left

31.2 ± 12.4

22.1 ± 11.4

Right

1.52 ± 0.21

0.99 ± 0.31

Left

1.41 ± 0.23

1.12 ± 0.18

With regard to tympanometric values, we could not
find any statistically significant difference among the
groups (P ˃ 0.05, Table 2).
4. Discussion
Although the diagnosis of FM is based on a particular
clinical presentation, the pathogenesis of FM appears to be
complex. Several abnormalities have been observed in FM
patients, some of which are notable:
1) Release of P substance (neurohormone) at high
levels in the cerebrospinal fluid;
2) Deficit of serotonin in the platelets;
3) Low levels of adenosine triphosphate;
4) Abnormal metabolism of carbohydrates in the red
blood cells;
5) Abnormal regulation of cortisol production;
6) Reduction of blood flow in certain brain structures
(8).
Heller et al. analyzed the incidence of phospholipid,
serotonin, and ganglioside antibodies and found that
these values were remarkably higher in patients with inner
ear disorders compared to the controls. They concluded
that increased antibody levels may indicate a possible
role in the development of the inner ear type of hearing
loss. Furthermore, these three antibodies were frequently
found in patients with FM syndrome, which may indicate
a similar mechanism in the etiopathogenesis of otologic
manifestations (9).
Normal inner ear function depends on maintenance of
homeostasis of the inner ear fluids and biochemical integrity
of auditory receptor cells. The sex and age differences in
human hearing function are well documented, and women
are known to exhibit shorter auditory brainstem response
latencies (10). FM syndrome is mostly seen in females.
Sensorineural deafness and auditory brainstem
response abnormalities were reported in 15% and 30%
of 168 fibromyalgia patients, respectively, suggesting that
fibromyalgia may be associated with inner ear or central
auditory impairment (11). Wolfe et al. (2) reported that the

prevalence of hearing difficulties among patients with FM
was 36.2%, which was significantly higher than in patients
with rheumatoid arthritis or osteoarthritis.
Auditory brainstem response (ABR) studies in FM
patients detected a pathway from the cochlea to the
brainstem in response to auditory stimuli. A study by
Bayazit et al. demonstrated several ABR abnormalities
in FM patients (3). They detected Eustachian tube
dysfunction due to obstructed or patulous Eustachian
tube in 19 of 32 ears with ear fullness, suggesting that ear
fullness in these 19 cases was not due to sensorineural
deafness but rather to Eustachian tube dysfunction (3).
In our study, there was a statistically significant difference
between the two groups in terms of tympanometric values
(P < 0.05). Tensor veli palatini muscle and levator veli
palatini muscle myopathy in FM patients may have caused
Eustachian tube dysfunction. The tensor veli palatini
muscle and levator veli palatini muscle are responsible for
the opening and closing of the Eustachian tube.
Contrary to studies supporting a causal relationship
for the development of hearing loss in FM, several reports
demonstrated no significant difference in the incidence of
deafness between healthy subjects and FM patients, with
no particularly higher incidence noted with patients (14–
16).
With regard to the result that mean air conduction
threshold values at high frequencies in the FM group
were lower than in the control groups, which was not
observed at low frequency thresholds, the difference
may be attributed to the fact that high frequencies are
more sensitive to the effects of phospholipid antibodies,
serotonin, and ganglioside antibodies (9).
Our findings suggest that FM patients should be
referred to ENT clinics for routine audiological evaluations.
The absence of evaluation of the phospholipid serotonin
and ganglioside antibodies in our study is a limitation of
our study design. We plan to investigate these parameters
combined with audiological evaluation in future studies.
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